| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Bad Answers/Good Answers: Discussing Teamwork In An Interview |
|
Main Subject - Bad Answers/Good Answers: Discussing Teamwork In An Interview
Everyone knows that they need to talk about their experiences at their former jobs and community activities in a job interview. However, what most people need work on is providing an interviewer with enough details so that they can actually picture you doing that activ According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ity. Let me give you an example: Question: Tell me about a time when you had to work with other people to pull together an assignment under a tight deadline. Here's an example of a candidate's typical response: The first thing I can ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in think of is a time when I was working in the arts. Our House Manager was out of the office on an extended leave when one of our conductor's unexpectedly passed away. He was well known in the community, so we decided to have a memorial concert in his honor. The concert lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. was going to be free to the public and had to be organized in only a few days. Since the House Manager was on leave, the CEO of the orchestra asked me to take the lead in coordinating the seating for the event. I decided to ask two friends of mine to help me. We decid here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe d to set up stanchions in front of the theater to help with crowd control. We also needed to count the number of people who were being let into the auditorium to make sure that everyone could find a seat. It was a big project, on short notice, but it went well. Everyon d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e found a seat and there really weren't any problems. I'm sure your first instinct is to say-well, that LOOKS long enough. What other meaningful details could she have provided that would have helped? She described the setup, the problem, who she asked to help and how ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc it resolved. However, can you actually picture anyone in this situation? Can you pinpoint exactly what role I played in this sound bite? Can you envision the numbers of people that were involved? Does this example look like it was tough to pull off? Read below easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi for the "enhanced" version. The first example that comes to mind is working in the arts. This was while I was the Season Tickets Director at the Atlanta Symphony. The House Manager-the person responsible for coordinating the ushers and handling all problems nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t the theater the night of the show-was out of the office on extended medical leave. One of our conductors-Robert Shaw-passed away unexpectedly. He was very well known in the community. In the span of a week, the orchestra coordinated a tribute concert. The problem was and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ that there wasn't enough time to have people call in for tickets, or do a waiting list. The theater holds 1100 patrons, and we were going to be able to use the other theaters in the arts center as well, so that number would have risen to closer to 2000 people. That's ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi just too many people to call in a short timeframe to order tickets, or pick them up the day of the performance. The CEO of the orchestra came to me and asked me to coordinate the theater arrangements for the day. The trick was how to handle potentially 2000 people wit ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a hout it turning into a mob scene. I asked two friends of mine to help. They were very smart, but also known for speaking out about things that weren't handled correctly. I knew if I had them on my team, then things would be done right. They understood that I was ultima dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ely responsible for the event, but were also proud that I had asked them for their expertise-I needed them. Between the three of us, we decided that the best bet was to put up stanchions in front of the theater so people could start to line up-and all seating would be cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin first come, first served. The day of the performance, one person stayed on the ground floor, another person went to the 2nd floor, and I stood on the stage where I could watch the patrons entering from all doors. When it started to look full, I told them to slow down t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen he number of people they were letting in, and then they could ask the rest of the people in line to get ready to walk to the other theaters down the hall. I remember that our CEO had been against the stanchions when we proposed them, but when she saw how well everythin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel g flowed that day, she came up to me later to praise me and my team, and admitted that we had a great idea. That meant a lot to us. Take a look at those 2 examples. Note the little details I added that give more weight to the example. First, I clearly ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust state where I was working when I had this experience. I then provide concrete numbers so my interviewer can picture just how many people were involved and the scope of the project. I also included information on specifically what the challenge was in coordinating the e y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products vent. I talked about why I chose my two friends to work with me. I provided details about what I specifically did the day of the event. In conclusion, I state that my CEO was pleased with the results, even more so because she had been against the plan in the beginning. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de Are you giving interviewers enough detail in your examples? Think of how you feel when a friend is telling you an especially captivating story that's rich with detail-it's like you're right there reliving it with them. You want your interviewer to feel the same way. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Don't worry about the length of the example necessarily--you don't want to ramble on for 20 minutes, but a detail-rich 3-4 minutes is good. © Red Inc. Melanie Szlucha. You can republish this information as long as the below paragraph is included exactly as it appears tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Change of the Retail World Hurdles to Cross Cultural Business Communication
|